Home » Public Citizen Wants ‘Unethical’ Canakinumab Trials Halted
Public Citizen Wants ‘Unethical’ Canakinumab Trials Halted
The watchdog group Public Citizen wants the FDA to immediately suspend two clinical trials involving canakinumab (Ilaris, Novartis) in light of safety concerns that caused an FDA advisory panel to vote against approving the drug for acute flares of gouty arthritis.
MedScape
MedScape
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May